Cargando…

Dominant Cross-Reactive B Cell Response during Secondary Acute Dengue Virus Infection in Humans

The four serotypes of dengue virus (DENV) cause dengue fever (DF) and dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS). Severe disease has been associated with heterotypic secondary DENV infection, mediated by cross-reactive antibodies (Abs) and/or cross-reactive T cells. The role of cross-r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zompi, Simona, Montoya, Magelda, Pohl, Marie O., Balmaseda, Angel, Harris, Eva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308930/ https://www.ncbi.nlm.nih.gov/pubmed/22448292 http://dx.doi.org/10.1371/journal.pntd.0001568

Ejemplares similares

Correlation between Dengue-Specific Neutralizing Antibodies and Serum Avidity in Primary and Secondary Dengue Virus 3 Natural Infections in Humans
por: Puschnik, Andreas, et al.
Publicado: (2013)

Intrahost Selection Pressures Drive Rapid Dengue Virus Microevolution in Acute Human Infections
por: Parameswaran, Poornima, et al.
Publicado: (2017)

Animal Models of Dengue Virus Infection
por: Zompi, Simona, et al.
Publicado: (2012)

Dissecting the human serum antibody response to secondary dengue virus infections
por: Patel, Bhumi, et al.
Publicado: (2017)

Symptomatic Versus Inapparent Outcome in Repeat Dengue Virus Infections Is Influenced by the Time Interval between Infections and Study Year
por: Montoya, Magelda, et al.
Publicado: (2013)

Impact of pre-existing dengue immunity on human antibody and memory B cell responses to Zika
por: Andrade, Paulina, et al.
Publicado: (2019)

Protective Immune Responses to Dengue Virus Infection and Vaccines: Perspectives from the Field to the Bench
por: Halstead, Scott B., et al.
Publicado: (2015)

Evaluation of ViroTrack Sero Zika IgG/IgM, a New Rapid and Quantitative Zika Serological Diagnostic Assay
por: Liao, Tony, et al.
Publicado: (2020)

The Nicaraguan Pediatric Dengue Cohort Study: Incidence of Inapparent and Symptomatic Dengue Virus Infections, 2004–2010
por: Gordon, Aubree, et al.
Publicado: (2013)

Analysis of Cross-Reactive Antibodies Recognizing the Fusion Loop of Envelope Protein and Correlation with Neutralizing Antibody Titers in Nicaraguan Dengue Cases
por: Lai, Chih-Yun, et al.
Publicado: (2013)

Temporal Dynamics of the Transcriptional Response to Dengue Virus Infection in Nicaraguan Children
por: Popper, Stephen J., et al.
Publicado: (2012)

Early Clinical Features of Dengue Virus Infection in Nicaraguan Children: A Longitudinal Analysis
por: Biswas, Hope H., et al.
Publicado: (2012)

Unusual Dengue Virus 3 Epidemic in Nicaragua, 2009
por: Gutierrez, Gamaliel, et al.
Publicado: (2011)

Boosting can explain patterns of fluctuations of ratios of inapparent to symptomatic dengue virus infections
por: Alexander, Laura W., et al.
Publicado: (2021)

Analysis of Individuals from a Dengue-Endemic Region Helps Define the Footprint and Repertoire of Antibodies Targeting Dengue Virus 3 Type-Specific Epitopes
por: Andrade, Daniela V., et al.
Publicado: (2017)

Viremia and Clinical Presentation in Nicaraguan Patients Infected With Zika Virus, Chikungunya Virus, and Dengue Virus
por: Waggoner, Jesse J., et al.
Publicado: (2016)

Cross-Reactivity and Expansion of Dengue-Specific T cells During Acute Primary and Secondary Infections in Humans
por: Friberg, Heather, et al.
Publicado: (2011)

Use of Urea Wash ELISA to Distinguish Zika and Dengue Virus Infections
por: Tsai, Wen-Yang, et al.
Publicado: (2018)

Phylodynamics of dengue virus 2 in Nicaragua leading up to the 2019 epidemic reveals a role for lineage turnover
por: Thongsripong, Panpim, et al.
Publicado: (2023)

High Dengue Case Capture Rate in Four Years of a Cohort Study in Nicaragua Compared to National Surveillance Data
por: Standish, Katherine, et al.
Publicado: (2010)

Evaluation of the Traditional and Revised WHO Classifications of Dengue Disease Severity
por: Narvaez, Federico, et al.
Publicado: (2011)

Effects of infection history on dengue virus infection and pathogenicity
por: Tsang, Tim K., et al.
Publicado: (2019)

Lower Low-Density Lipoprotein Cholesterol Levels Are Associated with Severe Dengue Outcome
por: Biswas, Hope H., et al.
Publicado: (2015)

Gene Expression Patterns of Dengue Virus-Infected Children from Nicaragua Reveal a Distinct Signature of Increased Metabolism
por: Loke, P'ng, et al.
Publicado: (2010)

Single-Reaction Multiplex Reverse Transcription PCR for Detection of Zika, Chikungunya, and Dengue Viruses
por: Waggoner, Jesse J., et al.
Publicado: (2016)

Dengue Viruses Are Enhanced by Distinct Populations of Serotype Cross-Reactive Antibodies in Human Immune Sera
por: de Alwis, Ruklanthi, et al.
Publicado: (2014)

Antibody-dependent enhancement of severe dengue disease in humans
por: Katzelnick, Leah C., et al.
Publicado: (2017)

Evaluation of the Diagnostic Utility of the Traditional and Revised WHO Dengue Case Definitions
por: Gutiérrez, Gamaliel, et al.
Publicado: (2013)

Adapting Rapid Diagnostic Tests to Detect Historical Dengue Virus Infections
por: Echegaray, Fernando, et al.
Publicado: (2021)

Prior dengue virus infection and risk of Zika: A pediatric cohort in Nicaragua
por: Gordon, Aubree, et al.
Publicado: (2019)

Tracking the polyclonal neutralizing antibody response to a dengue virus serotype 1 type-specific epitope across two populations in Asia and the Americas
por: Andrade, Daniela V., et al.
Publicado: (2019)

The possible role of cross-reactive dengue virus antibodies in Zika virus pathogenesis
por: Langerak, Thomas, et al.
Publicado: (2019)

Zika Virus Infection in Pregnancy: Advanced Diagnostic Approaches in Dengue-Naive and Dengue-Experienced Pregnant Women and Possible Implication for Cross-Reactivity and Cross-Protection
por: Zavattoni, Maurizio, et al.
Publicado: (2019)

CD4(+) T Cells Cross-Reactive with Dengue and Zika Viruses Protect against Zika Virus Infection
por: Wen, Jinsheng, et al.
Publicado: (2020)

Metabolomics-Based Discovery of Small Molecule Biomarkers in Serum Associated with Dengue Virus Infections and Disease Outcomes
por: Voge, Natalia V., et al.
Publicado: (2016)

Dengue virus-reactive CD8(+) T cells mediate cross-protection against subsequent Zika virus challenge
por: Wen, Jinsheng, et al.
Publicado: (2017)

COVID-19 serum can be cross-reactive and neutralizing against the dengue virus, as observed by the dengue virus neutralization test
por: Nath, Himadri, et al.
Publicado: (2022)

Augmented Zika and Dengue Neutralizing Antibodies Are Associated With Guillain-Barré Syndrome
por: Lynch, Rebecca M, et al.
Publicado: (2019)

Coincidence of Acute Brucella Hepatitis and Dengue Fever or Serologic Cross-reactivity?
por: Bzeizi, Khalid I., et al.
Publicado: (2010)

Cross-reactive Dengue virus-specific CD8(+) T cells protect against Zika virus during pregnancy
por: Regla-Nava, Jose Angel, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8cf1pdnp0usubdtealr2erl6u3